The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Valsartan / Hydrochlorothiazide Teva 80 mg/12.5 mg Film-coated tablets

80 mg/12.5 milligram(s) Film-coated tablet

Teva Pharma B.V.PA0749/047/001

Main Information

Trade NameValsartan / Hydrochlorothiazide Teva 80 mg/12.5 mg Film-coated tablets
Active SubstancesValsartan
Strength80 mg/12.5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/047/001

Group Information

ATC CodeC09DA Angiotensin II antagonists and diuretics
C09DA03 valsartan and diuretics


Licence Issued04/07/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0040-081-003
Interchangeable List DocumentPDF of Interchangeable List
« Back